Fractyl Health, Inc. Common Stock (GUTS) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Fractyl Health, Inc. Common Stock (US:GUTS), currently being evaluated. In 2024, Fractyl Health, Inc. Common Stock generated $93,000 in revenue and -$67.29 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Fractyl Health, Inc. Common Stock is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2024): $93,000
- Free Cash Flow (2024): -$67.29 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.